Breast cancer is the most common cancer in women in Europe: each year 350,000 new cases are diagnosed and each year about 130,000 women die of the disease. At the same time breast cancer is one of the few cancer types with encouraging healing prospects – if detected early.
Until now, interventional and endoscopic therapies have held little importance in common cancer treatment. However, given the trend towards personalised medicine and targeted cancer therapy, increasing attention is being paid to reasonable complements to traditional cancer surgery.
Although modern respirators present ever increasing features to enhance and simplify ventilation therapy, methods to quantify the efficacy of ventilator changes are limited.